Alpha 2.0
Login Register
» Authors » V Aoki

V Aoki

Explore the profile of V Aoki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 571
Followers 0
Related Specialties
Dermatology
Infectious Diseases
General Medicine
Top 10 Co-Authors
L A Diaz
C W Maruta
E A Rivitti
M N Sotto
C G Santi
D Miyamoto
G Hans-Filho
M N Sato
N V Pereira
G J Giudice
Published In
J Eur Acad Dermatol Venereol
Clin Exp Dermatol
Br J Dermatol
J Invest Dermatol
Clin Dermatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Increased expression of in situ CD123 and reduced Toll-like receptor 7/9 signalling pathway suggest impaired activation of plasmacytoid dendritic cells in recurrent erythema multiforme
Dias de Oliveira N, Santi C, Maruta C, Miyamoto D, Pereira N, Sotto M, et al.
J Eur Acad Dermatol Venereol . 2024 Feb; 38(9):e816-e819. PMID: 38407349
No abstract available.
2.
Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab
Gordilho J, Miyamoto D, Maruta C, Santo R, Mahmoud A, Navarro-Rodriguez T, et al.
J Eur Acad Dermatol Venereol . 2023 Aug; 38(1):e45-e47. PMID: 37565448
No abstract available.
3.
Unfolding the worldwide incidence of bullous pemphigoid: what are we missing?
Aoki V, Miyamoto D
Br J Dermatol . 2021 Nov; 186(3):386-387. PMID: 34806169
No abstract available.
4.
Increased expression of Filaggrin and Claudin-1 in the ocular surface of patients with atopic dermatitis
Callou T, Orfali R, Sotto M, Pereira N, Zaniboni M, Aoki V, et al.
J Eur Acad Dermatol Venereol . 2021 Oct; 36(2):247-254. PMID: 34704317
Background: Atopic dermatitis (AD) is an itchy, chronic and inflammatory skin condition, with dysfunctional immune response and skin barrier defects. Reduction of filaggrin (FLG) and tight junctions (TJ) proteins, such...
5.
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force
Misery L, Belloni Fortina A, El Hachem M, Chernyshov P, von Kobyletzki L, Heratizadeh A, et al.
J Eur Acad Dermatol Venereol . 2020 Oct; 35(4):787-796. PMID: 33090558
Atopic dermatitis (AD) is a disease that can have a high impact on quality of life, especially due to itch and skin pain. This paper utilizes expertise from members of...
6.
Increased expression of in situ IL-31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL-31 family in the pathogenesis of the disease
Morais K, Miyamoto D, Orfali R, Maruta C, Santi C, Sotto M, et al.
J Eur Acad Dermatol Venereol . 2020 Jun; 34(12):2890-2897. PMID: 32531145
Background: Pemphigus herpetiformis (PH) is a rare clinical subtype of pemphigus with the presence of urticarial plaques, severe pruritus, rare acantholysis and eosinophilic spongiosis. Objectives: The aim of this study...
7.
Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT Study
Arruda L, Yang A, Aoki V, Criado R, Pires M, Lupi O, et al.
J Investig Allergol Clin Immunol . 2020 Jan; 31(3):236-245. PMID: 31932275
Background: Atopic dermatitis is a chronic inflammatory skin disease with a prevalence of 0.02% to 8.1% in adults. Adult patients with moderate-to-severe atopic dermatitis are affected by frequent relapses and...
8.
Lichen planus: altered AIM2 and NLRP1 expression in skin lesions and defective activation in peripheral blood mononuclear cells
Domingues R, Pietrobon A, Carvalho G, Pereira N, Pereira N, Sotto M, et al.
Clin Exp Dermatol . 2018 Dec; 44(4):e89-e95. PMID: 30552699
Background: Lichen planus (LP) is an inflammatory skin disease with unknown aetiology. Activation by pathogen-associated molecular patterns or environmental stimuli may activate some components of inflammasomes that contribute to the...
9.
Beta-adrenoceptor expression in pemphigus foliaceus
Miyamoto D, Dias A, Aoki V, Burnier Jr M
J Eur Acad Dermatol Venereol . 2018 May; 32(12):e459-e461. PMID: 29730879
No abstract available.
10.
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
Chalmers J, Thomas K, Apfelbacher C, Williams H, Prinsen C, Spuls P, et al.
Br J Dermatol . 2018 Apr; 178(5):e332-e341. PMID: 29672835
This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with...